Wholesale of pharmaceutical and medical goods
WELLSPECT AS
Revenue 2024
NOK 93.4m
Operating profit
NOK −4.3m
Equity
NOK 6.2m
Incorporated
2021
Employees
5
Share capital
NOK 60,000
Financials
Total operating revenue
Operating profit (EBIT)
Income statement
| Post | 2024 | Trend |
|---|---|---|
| Total operating revenue | 93.4m | |
| Total operating costs | 97.8m | |
| Operating profit (EBIT) | −4.3m | |
| Net financial items | −1.2m | |
| Profit for the year | −4.3m |
Balance sheet
| Post | 2024 | Trend |
|---|---|---|
| Total assets | 72.4m | |
| of which current assets | 50.5m | |
| Equity | 6.2m | |
| Total liabilities | 66.2m |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.